Skip to main content
SpringerLink
Log in

Overview and the Future of Obesity Treatment

  • Chapter
The Management of Eating Disorders and Obesity

Part of the book series: Nutrition ◊ and ◊ Health ((NH))

  • 215 Accesses

Abstract

The focus of this chapter will be to address the future of obesity treatment. After a brief background related to the importance of obesity treatment owing to the socioeconomic and personal costs, we briefly review the effectiveness of current interventions so that we can assess the past and present of obesity treatment. We then examine current issues and controversies that we believe will affect the future of obesity treatment, including the changing definition of obesity, whether short-term changes in weight and normalization of comorbid conditions translate into long-term improvements in health, the cost-effectiveness and feasibility of long-term treatment to improve maintenance of weight loss, the shift toward more comprehensive health models in obesity treatment, and promising directions in the prevention of obesity. Table 1 provides an overview of the organization of the chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI). Clinical guidelines on the indentification, evaluation, and treatment of overweight and obesity: The evidence report. Washington, DC:Printing Office, US Government, 1998.

    Google Scholar 

  2. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to dyslipidemia in white American women. Arch Intern Med 1994; 154: 401–410.

    Article  CAS  Google Scholar 

  3. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American women. Arch Intern Med 1993; 153: 1093–1103.

    Article  CAS  Google Scholar 

  4. MacMahon S, Cutler J, Brittain E, Higgins, M. Obesity and hypertension: Epidemiological and clinical issues. Eur Heart J 1987; 8 (Suppl B): 57–70.

    Article  Google Scholar 

  5. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119 (7 Pt 2): 655–660.

    CAS  Google Scholar 

  6. Solomon CG, Willett WC, Manson JE. Body weight and mortality. In: Van Itallie TB, Simonpoulos AP, eds. Obesity: New Directions in Assessment and Management. Charles, Philadelphia, PA, 1995, pp. 1–11.

    Google Scholar 

  7. Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord 1996; 20: 63–75.

    CAS  Google Scholar 

  8. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677–685.

    Article  CAS  Google Scholar 

  9. Wolf AM, Colditz GA. The cost of obesity: the U.S. perspective. PharmacoEconomics 1994; 5 (Suppl 1): 34–37.

    Article  CAS  Google Scholar 

  10. Wolf AM, Colditz GA: Social and economic effects of body weight in the United States. Am J Clin Nutr 1996; 63 (Suppl): 466S - 469S.

    Google Scholar 

  11. Colditz GA. Economic costs of obesity. Am J Clin Nutr 1992; 55: 503S - 507S.

    Google Scholar 

  12. Sjöström L, Narbro, K, Sjöström D. Costs and benefits when treating obesity. Int J Obes Relat Metab Disord 1995;;19(Suppl 6 ): S9 - S12.

    Google Scholar 

  13. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993; 329: 1008–1012.

    Article  CAS  Google Scholar 

  14. Enzi G. Socioeconomic consequences of obesity: the effect of obesity on the individual. PharmacoEconomics 1994; 5 (Suppl 1): 54–57.

    Article  CAS  Google Scholar 

  15. Sarlio-Lähteenkorva S, Stunkard AJ, Rissanen A. Psychosocial factors and quality of life in obesity. Int J Obes Relat Metab Disord 1995; 19 (Suppl 6): S1-S5.

    Google Scholar 

  16. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320–328.

    CAS  Google Scholar 

  17. Kanders BS, Blackburn GL. Reducing primary risk factors by therapeutic weight loss. In: Wadden TA, VanItallie TB, eds. Treatment of the Seriously Obese Patient. Guilford, New York, NY, 1992, pp. 213–230.

    Google Scholar 

  18. Foreyt JP, Goodrick GK. Attributes of successful approaches to weight loss and control. Appl Prevent Psychol 1994; 3: 209–215.

    Article  Google Scholar 

  19. Perri MG, Fuller PR. Success and failure in the treatment of obesity: Where do we go from here? Med Exercise Nutr Health 1995; 4: 255–272.

    Google Scholar 

  20. Stunkard AJ. An overview of current treatments for obesity. In: Wadden TA, VanItallie TB, eds. Treatment of the Seriously Obese Patient. Guilford, New York, NY, 1992, pp. 33–43.

    Google Scholar 

  21. Kramer FM, Jeffery RW, Forster JL, Snell MK. Long-term follow-up of behavioral treatment for obesity: Patterns of weight gain among men and women. Int J Obes Relat Metab Disord 1989; 13: 124–136.

    Google Scholar 

  22. Stalonas PM, Perri MG, Kerzner AB. Do behavioral treatments of obesity last? A five-year follow-up investigation. Addict Behav 1984; 9: 175–184.

    Article  CAS  Google Scholar 

  23. Wadden TA, Sternberg JA, Letizia KA, Stunkard M, Foster GD. Treatment of obesity by very low calorie diet, behavioral therapy, and their combination: a five-year perspective. Int J Obes Relat Metab Disord 1989; 13 (Suppl 2): 39–46.

    Google Scholar 

  24. Perri MG, Nezu AM, Viegener BJ. Improving the Long-Term Management of Obesity: Theory, Research, and Clinical Guidelines. Wiley, New York, NY, 1992, pp. 3–124.

    Google Scholar 

  25. Perri MG, Shapiro RM, Ludwig WW, Twentyman CT, McAdoo WG. Maintenance strategies for the treatment of obesity: An evaluation of relapse prevention training and posttreatment contact by mail and telephone. J Consult Clin Psychol 1984; 52: 404–413.

    Article  CAS  Google Scholar 

  26. Perri MG, McAdoo WG, McAllister DA, Lour JB, Jordan RC, Yancey DZ, et al. Effects of peer support and therapist contact on long-term weight loss. J Consult Clin Psychol 1987; 55: 615–617.

    Article  CAS  Google Scholar 

  27. Perri MG, McAllister DA, Gange JJ, Jordan RC, McAdoo WG, Nezu AM. Effects of four maintenance programs on the long-term management of obesity. J Consult Clin Psychol 1988; 56: 529–534.

    Article  CAS  Google Scholar 

  28. Baum JG, Clark HB, Sandler J. Preventing relapse in obesity through posttreatment maintenance systems: comparing the relative efficacy of two levels of therapist support. J Behav Med 1991; 14: 287–302.

    Article  CAS  Google Scholar 

  29. Bray GA. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med 1993; 119 (7 pt 2): 707–713.

    CAS  Google Scholar 

  30. Stunkard AJ, Harris JR, Pederson NL, McClearn GE. The body mass of twins reared apart. N Engl J Med 1990; 322: 1483–1487.

    Article  CAS  Google Scholar 

  31. Craighead LW, Stunkard AJ, O’Brien M. Behavior therapy and pharmacotherapy for obesity. Archiv Gen Psychiatry 1981; 38: 763–768.

    Article  CAS  Google Scholar 

  32. Stunkard AJ, Craighead LW, O’Brien R. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet 1980; 2 (8203): 1045–1047.

    Article  CAS  Google Scholar 

  33. Craighead LW. Sequencing of behavior therapy and pharmacotherapy for obesity. J Consult Clin Psychol 1984; 52: 190–199.

    Article  CAS  Google Scholar 

  34. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581 588.

    Google Scholar 

  35. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. JAMA 1996; 335: 609–616.

    CAS  Google Scholar 

  36. Centers for Disease Control (CDC). Cardiac valvulopathy associated with fenfluramine or dexfenfluramine. U.S. Department of Health and Human Services Interim Public Health Recommendations, November 1997. MMWR 1997; 46: 1061–1066.

    Google Scholar 

  37. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefevre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet 1989; 2 (8672): 1142–1144.

    Article  CAS  Google Scholar 

  38. Guy-Grand B. INDEX (International Dexfenfluramine study) as a model for long-term pharmacotherapy of obesity in the 1990’s. Int J Obes Relat Metab Disord 1992; 16 (Suppl 3): S5-S14.

    Google Scholar 

  39. Guy-Grand B. Clinical studies with dexfenfluramine: from past to future. Obes Res 1995; 3 (Suppl 4): 491S - 496S.

    Article  Google Scholar 

  40. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefevre P, Turner P. Effect of withdrawal of dexfenfluramine on body weight and food intake after one year’s administration. Int J Obes Relat Metab Disord 1990; 14 (Suppl 2): 48.

    Google Scholar 

  41. O’Connor HT, Richman RM, Steinbeck KS, et al. Dexfenfluramine treatment of obesity: A double blind trial with post trial follow up. Int J Obes Relat Metab Disord 1995; 19: 181–189.

    Google Scholar 

  42. Pfohl M, Luft D, Bloomberg I, Schmulling RM. Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine. Int J Obes Relat Metab Disord 1994; 18: 391–395.

    CAS  Google Scholar 

  43. Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, Lasagna L, et al. Long-term weight control study I (weeks 0 to 34): the enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 1992; 51: 586–594.

    Article  CAS  Google Scholar 

  44. Weintraub M, Sundaresan PR, Schuster B, Madan M, Ginsberg G, Balder A, et al. Long-term weight control study II (weeks 34 to 104): an open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise. Clin Pharmacol Ther 1992; 51: 595–601.

    Article  CAS  Google Scholar 

  45. Weintraub M, Sundaresan PR, Schuster B, Moscucci M, Stein EC. Long-term weight control study III (weeks 104 to 156): an open-label study of dose adjustment of fenfluramine and phentermine. Clin Pharmacol Ther 1992; 51: 602–607.

    Article  CAS  Google Scholar 

  46. Weintraub M. Long-term weight control study: Conclusions. Clin Pharmacol Ther 1992; 51: 642–646.

    Article  CAS  Google Scholar 

  47. Atkinson RL, Blank RC, Loper JF, Schumacher D, Lutes RA. Combined drug treatment of obesity. Obes Res 1995; 3 (Suppl 4): 497S - 500S.

    Article  Google Scholar 

  48. Sayler ME, Goldstein DJ, Roback PJ, Atkinson RL. Evaluating success of weight loss programs, with an application to fluoxetine weight reduction clinical trial data. Int J Obes Relat Metab Disord 1994; 18: 742–751.

    CAS  Google Scholar 

  49. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and nonbinge-eaters. Am J Psychiatry 1990; 147: 876–881.

    CAS  Google Scholar 

  50. Goldstein DJ, Rampey AH, Enas GG, Potvin JH, Fludzinski LA, Levine LR. Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes Relat Metab Disord 1994; 18: 129–135.

    CAS  Google Scholar 

  51. Goldstein DJ, Rampey AH, Roback PJ, Wilson MG, Hamilton SH, Sayler ME, et al. Efficacy and safety of long-term fluoxetine treatment of obesity-Maximizing success. Obes Res 1995; 3 (Suppl 4): 481S - 490S.

    Article  Google Scholar 

  52. Goldstein DJ, Roback PJ, Holman SL, Wilson MG, Tollefson ED, Brunelle RL, et al. Individualizing pharmacological therapy for weight reduction: the Lovan example. In: Vanitallie TB, Simonpoulos AP, eds. Obesity: New Directions in Assessment and Management. Charles, Philadelphia, PA, 1995, pp. 234–240.

    Google Scholar 

  53. Drent ML, van der Veen EA. Lipase inhibition: a novel concept in the treatment of obesity. Int J Obes Relat Metab Disord 1993; 17: 241–244.

    CAS  Google Scholar 

  54. Drent ML, Larsson I, William-Olsson T, Quaade F, Czubaybo F, von Bergmann K, et al. Orlistat (RO 18–0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes Relat Metab Disord 1995; 19: 221–226

    CAS  Google Scholar 

  55. Drent ML, van der Veen EA. First clinical studies with orlistat: A short review. Obes Res 1995; 3 (Suppl 4): 623S - 625S.

    Article  Google Scholar 

  56. James WPT, Avenell A, Broom J, Whitehead J. A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord 1997; 21 (Suppl 3): S24 - S30.

    Google Scholar 

  57. Ryan DH, Kaiser P, Bray GA. Sibutramine: a novel new agent for obesity treatment. Obes Res 1995; 3 (Suppl 4): 553S–559S.

    Article  Google Scholar 

  58. Stock MJ. Sibutramine-A review of the pharmacology of a novel anti-obesity agent. Int J Obes Relat Metab Disord 1997; 21 (Suppl 1): S25 - S29.

    Google Scholar 

  59. Lean MEJ. Sibutramine-A review of clinical efficacy. Int J Obes Relat Metab Disord 1997; 21 (Suppl 1): S30 - S36.

    Google Scholar 

  60. Wadden TA, Bartlett SJ, Foster GD, Greenstein RA, Wingate BJ, Stunkard AJ, et al. Sertraline and relapse prevention training following treatment by Very-Low-Calorie-Diet: a controlled clinical trial. Obes Res 1995; 3: 549–558.

    Article  CAS  Google Scholar 

  61. National Task Force on the Prevention and Treatment of Obesity. Very low-calorie diets. JAMA 1993; 270: 967–974.

    Google Scholar 

  62. Wadden TA, Bartlett SJ. Very low calorie diets: An overview and appraisal. In: Wadden TA, VanItallie TB, eds. Treatment of the Seriously Obese Patient. Guilford, New York, NY, 1992, pp. 44–79.

    Google Scholar 

  63. Kral JG. Surgical treatment of obesity. In Wadden TA, Vanitallie TB, eds. Treatment of the Seriously Obese Patient. Guilford, New York, NY, 1992, 496–506.

    Google Scholar 

  64. Benotti PN, Forse RA. The role of gastric surgery in the multidisciplinary management of severe obesity. Am J Surg 1995; 169: 361–367.

    Article  CAS  Google Scholar 

  65. Martin LF, Tan TL, Horn JR,Bixler EO, Kauffman GL, Becker DA, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 1995; 118: 599–607.

    Article  CAS  Google Scholar 

  66. Simonpoulos AP. Body weight reference standards. In: Vanitallie TB, Simonpoulos AP, eds. Obesity: new directions in assessment and management. Charles, Philadelphia PA, 1995, pp. 12–21.

    Google Scholar 

  67. Garner DM, Wooley SC. Confronting the failure of behavioral and dietary treatments for obesity. Clin Psychol Rev 1991; 11: 729–780.

    Article  Google Scholar 

  68. Brownell KD, Wadden TA. Etiology and treatment of obesity: understanding a serious, prevalent, and refractory disorder. J Consult Clin Psychol 1992; 60: 505–517.

    Article  CAS  Google Scholar 

  69. Foreyt JP, Poston WSC, Goodrick GK. Future directions in obesity and eating disorders. Addict Behav 1996; 21: 767–778.

    Article  CAS  Google Scholar 

  70. Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight-Management Programs. National Academy Press, Washington DC, 1995, pp. 37–63.

    Google Scholar 

  71. Bender R, Trautner C, Spraul M, Berger M. Assessment of excess mortality in obesity. Am J Epidemiol 1998; 147: 42–48.

    Article  CAS  Google Scholar 

  72. Williamson DF, Pamuk ER. The association between weight loss and increased longevity: a review of the evidence. Ann Intern Med 1993; 119 (7 Pt 2): 731–736.

    CAS  Google Scholar 

  73. Andres R, Muller DC, Sorkin JD. Long-term effects of change in body weight on all-cause mortality: a review. Ann Intern Med 1993; 119 (7 Pt 2): 737–743.

    CAS  Google Scholar 

  74. Williamson DF, Pamuk ER, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight U.S. white women aged 40–64 years. Am J Epidemiol 1995; 141: 1128–1141.

    CAS  Google Scholar 

  75. Foster GD, Sarwer DB, Wadden TA. Psychological effects of weight cycling in obese persons-A review and research agenda. Obes Res 1997; 5: 474–488.

    Article  CAS  Google Scholar 

  76. Blair SN, Shaten J, Brownell K, Collins G, Lissner L. Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med 1993; 119 (7 Pt 2): 749–757.

    CAS  Google Scholar 

  77. Iribarren C, Sharp DS, Burchfiel CM, Petrovich H. Association of weight loss and weight fluctuation with mortality in Japanese American men. N Engl J Med 1995; 333: 686–692.

    Article  CAS  Google Scholar 

  78. National Task Force on the Prevention and Treatment of Obesity. Weight cycling. JAMA 1994; 272: 1196–1202.

    Google Scholar 

  79. Venditti EM, Wing RR, Jakicic JM, Butler BA, Marcus MD. Weight cycling, psychological health, and binge eating in obese women. J Consult Clin Psychol 1996; 64: 400–405.

    Article  CAS  Google Scholar 

  80. Foreyt JP, Brunner RL, Goodrick GK, Cutter G, Brownell KD, St. Jeor ST. Psychological correlates of weight fluctuation. Int J Eat Disord 1995; 17: 263–275.

    Article  CAS  Google Scholar 

  81. Yanovski SZ. Are anorectic agents the “magic bullet” for obesity? Arch Fam Med 1993; 2: 1025–1027.

    Article  CAS  Google Scholar 

  82. Gullo SP. Food control training as a successor to dieting: A new model for weight management. In: Vanitallie TB, Simonpoulos AP, eds. Obesity: New Directions in Assessment and Management. Charles, Philadelphia, PA, 1995, pp. 153–171.

    Google Scholar 

  83. Perri MG. Improving maintenance of weight loss following treatment by diet and lifestyle modification. In: Wadden TA, Vanitallie TB, eds. Treatment of the Seriously Obese Patient. Guilford, New York, NY, 1992, pp. 456–477.

    Google Scholar 

  84. Guy-Grand B. Long-term pharmacological treatment of obesity. In: Wadden TA, VanItallie TB, eds. Treatment of the Seriously Obese Patient. Guilford, New York, NY, 1992, pp. 478–495.

    Google Scholar 

  85. Institute of Medicine. Weighing the Options: Criteria for evaluating weight-management programs. National Academy Press, Washington DC, 1995, pp. 152–170.

    Google Scholar 

  86. Fries JF, Koop, CE, Beadle CE, Cooper PP, England MJ, Greaves RF, et al. Reducing health care costs by reducing the need and demand for medical services. N Engl J Med 1993; 329: 321–325.

    Article  CAS  Google Scholar 

  87. Foreyt JP, Goodrick GK. The ultimate triumph of obesity. Lancet 1995; 346: 134–135.

    Article  CAS  Google Scholar 

  88. Curb JD, Marcus EB. Body fat and obesity in Japanese Americans. Am J Clin Nutr 1991; 53: 1552S - 1555S.

    Google Scholar 

  89. James WPT. A public health approach to the problem of obesity. Int J Obes Relat Metab Disord 1995; 19 (Suppl 3): 537 - S45.

    Google Scholar 

  90. Lissner L, Heitman BL. Dietary fat and obesity: Evidence from epidemiology. Eur J Clin Nutr 1995; 49: 79–90.

    CAS  Google Scholar 

  91. Battle EK, Brownell KD: Confronting a rising tide of eating disorders and obesity: treatment vs. prevention and policy. Addict Behav 1996; 21: 755–765.

    Article  CAS  Google Scholar 

  92. Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight-Management Programs. National Academy Press, Washington DC, 1995, pp. 102–117.

    Google Scholar 

  93. USDHHS. Physical activity and health: A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA, 1996.

    Google Scholar 

  94. Grilo CM. The role of physical activity in weight loss and weight loss management. Med Exercise Nutr Health 1995; 4: 60–76.

    Google Scholar 

  95. Klem ML, Wing RR, McGuire MT, Seagle HM, Hill JO. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr 1997; 66: 239–246.

    CAS  Google Scholar 

  96. Barlow CE, Kohl HW, Gibbons LW, Blair SN. Physical fitness, mortality, and obesity. Int J Obes Relat Metab Disord 1995; 19 (Suppl 4): S41 - S44.

    Google Scholar 

  97. Dorner G, Plagemann A. Perinatal hyperinsulinism as a possible predisposing factor for diabetes mellitus, obesity, and enhanced cardiovascular risk in later life. Horm Metab Res 1994; 26: 213–221.

    Article  CAS  Google Scholar 

  98. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension, and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62–67.

    Article  CAS  Google Scholar 

  99. Fall CH, Vijayakumar M, Barker DJ, Osmond C, Duggleby S. Weight in infancy and prevalence of coronary heart disease in adult life. Br Med J 1995; 310 (6971): 17–19.

    Article  CAS  Google Scholar 

  100. Bowen DJ, Tomoyasu N, Cauce AM. The triple threat: A discussion of gender, class, and race differences in weight. Women Health 1991; 17: 123–143.

    CAS  Google Scholar 

  101. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol 1994; 13: 373–383.

    Article  CAS  Google Scholar 

  102. Burke LE, Dunbar-Jacobs J. Adherence to medication, diet, and activity recommendations: From assessment to maintenance. J Cardiovasc Nurs 1995; 9: 62–79.

    CAS  Google Scholar 

  103. Kirschenbaum DS, Fitzgibbon ML. Controversy about the treatment of obesity: Criticisms or challenges? Behav Ther 1995; 26: 43–68.

    Article  Google Scholar 

  104. Anonymous. Daily dietary fat and total food-energy intakes-Third National Health and Nutrition Examination Survey, Phase 1, 1988–91. MMWR 1994; 43: 116–124.

    Google Scholar 

  105. Burkitt DP, Eaton SB. Putting the wrong fuel in the tank. Nutrition 1989; 5: 189–191

    CAS  Google Scholar 

  106. Whitaker RC, Wright JA, Finch AJ, Deyo RA, Psaty BM. School lunch: A comparison of the fat and cholesterol content with dietary guidelines. J Pediatr 1993; 123: 857–62.

    Google Scholar 

  107. Chapman N, Gordon AR, Burghardt JA. Factors affecting the fat content of National School Lunch Program lunches. Am J Clin Nutr 1995; 61 (Suppl 1): 199S - 204S.

    Google Scholar 

  108. Goodman WC. The Invisible Woman: Confronting Weight Predjudice in America. Gürze Books, Carlsbad, CA, 1995, pp. 18–45.

    Google Scholar 

  109. Eaton SB. Humans, lipids and evolution. Lipids 1992; 27: 814–820.

    Article  CAS  Google Scholar 

  110. Andersen RE, Wadden TA, Bartlett SJ, Vogt RA, Weinstock RS. Relation of weight loss to changes in serum lipids and lipoproteins in obese women. Am J Clin Nutr 1995; 62: 350–357.

    CAS  Google Scholar 

  111. Björntorp P. Evolution of the understanding of the role of exercise in obesity and its complications. Int J Obes Relat Metab Disord 1995; 19 (Suppl 4): S1 - S4.

    Google Scholar 

  112. Wooley SC. Maelstrom revisited. Am Psychol 1995; 50: 943–944.

    Article  Google Scholar 

  113. Foreyt JP, Goodrick GK. Living Without Dieting. Warner Books, New York, NY 1994, pp. 15–126.

    Google Scholar 

Download references

Authors
  1. John P. Foreyt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walker S. C. Poston II
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lilly Research Laboratories, Indiana University School of Medicine, Indianapolis, IN, USA

    David J. Goldstein MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Foreyt, J.P., Poston, W.S.C. (1999). Overview and the Future of Obesity Treatment. In: Goldstein, D.J. (eds) The Management of Eating Disorders and Obesity. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-694-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-694-2_12

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6761-2

  • Online ISBN: 978-1-59259-694-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation